A&P LIFESCIENCE FUND, FI
•CLASE A
Valor Liquidativo
Patrimonio
Cartera Renta Variable
Activo | Div. | Valor | Peso | Dif. |
---|---|---|---|---|
US38000Q1022 GlycoMimetics Inc | EUR | 129.805 € | 4.77% | 396.31% |
NL0010696654 Uni-Pixel Inc. | EUR | 86.889 € | 3.19% | 19.11% |
US02043Q1076 Alnylam Pharmaceutic | EUR | 77.256 € | 2.84% | 59.58% |
US05464T1043 Axsome Therapeutics | EUR | 76.878 € | 2.83% | 97.23% |
US8006771062 Sangamo Therapeutics | EUR | 59.984 € | 2.2% | 145.12% |
US3723032062 Genmab A/S | EUR | 58.394 € | 2.15% | 27.75% |
US09061G1013 Biostar Pharmaceutic | EUR | 56.265 € | 2.07% | 22.3% |
US52490G1022 Legend Biotech Corp | EUR | 54.373 € | 2% | 11.11% |
US81181C1045 Seattle Genetics Inc | EUR | 53.781 € | 1.98% | 28.87% |
US5324571083 Lilly (Eli) & Co. | EUR | 53.313 € | 1.96% | 10.5% |
US4622221004 Ionis Pharmaceutical | EUR | 52.642 € | 1.94% | 0.08% |
US65487U1088 Nkarta Inc | EUR | 50.639 € | 1.86% | 91.78% |
US04280A1007 Arrowhead Pharmaceut | EUR | 49.331 € | 1.81% | 342.43% |
CH0499880968 ADC Therapeutics SA | EUR | 47.967 € | 1.76% | 69.77% |
US87164F1057 Descom Inc | EUR | 47.500 € | 1.75% | 29.54% |
US73730P1084 Poseida Therapeutics | EUR | 46.712 € | 1.72% | 747% |
US04016X1019 ARGENX SE | EUR | 46.712 € | 1.72% | 2.08% |
US45253H1014 ImmunoGen Inc | EUR | 45.949 € | 1.69% | 420.2% |
US0311621009 Amgen Inc. | EUR | 45.634 € | 1.68% | 5.72% |
US45337C1027 IncytCor | EUR | 43.743 € | 1.61% | 3.54% |
US00847X1046 Agios Pharmaceutical | EUR | 40.789 € | 1.5% | 24.04% |
DE0006632003 Morphosys AG | EUR | 39.115 € | 1.44% | 95.25% |
US8036071004 Sarepta Therapeutics | EUR | 33.530 € | 1.23% | 69.3% |
US45665G3039 Infinity Pharmaceuti | EUR | 33.093 € | 1.22% | Nueva |
US07725L1026 Beigene ltd-adr | EUR | 32.873 € | 1.21% | 33.08% |
US09075P1057 Bioxcel Therapeutics | EUR | 30.038 € | 1.1% | 59.37% |
US45781K2042 Innate Pharma SA | EUR | 29.366 € | 1.08% | 35.3% |
US60468T1051 Mirati Therapeutics | EUR | 29.290 € | 1.08% | 33.9% |
US0327241065 AnaptysBio Inc | EUR | 28.225 € | 1.04% | 49.5% |
NL0010872420 Affimed NV | EUR | 27.529 € | 1.01% | 16.57% |
US8835561023 Thermo Electron Corp | EUR | 27.264 € | 1% | 0.73% |
US03969F1093 Arcus Biosciences In | EUR | 26.813 € | 0.99% | 20.08% |
US00287Y1091 AbbVie Inc | EUR | 26.419 € | 0.97% | 3.34% |
US0197701065 AllogeneTherapeutics | EUR | 26.112 € | 0.96% | 45.96% |
US24823R1059 Denali Therapeutics | EUR | 25.459 € | 0.94% | Nueva |
US1011371077 Accs. Boston Scienti | EUR | 25.501 € | 0.94% | 21.58% |
US0028241000 Abbott Laboratories | EUR | 25.537 € | 0.94% | 1.04% |
US45720L1070 Inhibrx Inc | EUR | 24.260 € | 0.89% | Nueva |
US7291391057 Pliant Therapeutics | EUR | 23.962 € | 0.88% | 136.33% |
US7711951043 ROCHE HOLDING | EUR | 23.698 € | 0.87% | 8.08% |
US03890D1081 Aravive Inc | EUR | 23.266 € | 0.86% | Nueva |
US4497781090 IO Biotech Inc | EUR | 23.185 € | 0.85% | Nueva |
US66987V1098 NOVARTIS AG-REG SHS | EUR | 22.797 € | 0.84% | 5.11% |
US30063P1057 Exact Sciences Corp | EUR | 22.338 € | 0.82% | 23.09% |
US75886F1075 Regeneron Pharmaceut | EUR | 22.241 € | 0.82% | 19.53% |
US00166B1052 ALX Oncology Holding | EUR | 21.550 € | 0.79% | 36.43% |
US98401F1057 Xencor Inc | EUR | 21.187 € | 0.78% | 6.83% |
US00653A1079 Adaptimmune Therapeu | EUR | 20.811 € | 0.77% | 15.89% |
US04335A1051 Arvinas Inc | EUR | 20.932 € | 0.77% | 20.4% |
US76029N1063 Replimune Group Inc | EUR | 20.352 € | 0.75% | 52.39% |
US00461U1051 Aclaris Therapeutics | EUR | 20.201 € | 0.74% | Nueva |
IE00BTN1Y115 Medtronic INC | EUR | 19.893 € | 0.73% | 15.19% |
US70975L1070 Penumbra Inc | EUR | 19.534 € | 0.72% | 74.96% |
CH0334081137 CRISPR Therapeutics | EUR | 19.024 € | 0.7% | 34.49% |
US09609G1004 Bluebird Bio Inc | EUR | 18.604 € | 0.68% | Nueva |
US31189P1021 Fate Therapeutics In | EUR | 17.579 € | 0.65% | 82.3% |
US0327973006 Anavex Life Sciences | EUR | 15.821 € | 0.58% | 9.4% |
US46565G1040 iTeos Therapeutics I | EUR | 15.015 € | 0.55% | 7.15% |
US45166A1025 Ideaya Biosciences I | EUR | 14.920 € | 0.55% | 28.95% |
US05153U1079 Aura Biosciences Inc | EUR | 13.683 € | 0.5% | Nueva |
US09077B1044 BioAtla Inc | EUR | 13.309 € | 0.49% | 183.47% |
US09077A1060 Biomea Fusion Inc | EUR | 12.489 € | 0.46% | 31.09% |
US4923271013 Keros Therapeutics I | EUR | 12.201 € | 0.45% | 70.21% |
US3441741077 Foghorn Therapeutics | EUR | 10.495 € | 0.39% | 54.06% |
US4523271090 Illumina Inc | EUR | 10.577 € | 0.39% | 7.4% |
US40131M1099 Guardant Health Inc | EUR | 8385 € | 0.31% | 33.97% |
US05280R1005 Autolus Therapeutics | EUR | 6745 € | 0.25% | 34.25% |
US0887861088 Bicycle Therapeutics | EUR | 5475 € | 0.2% | 72.77% |
US75943R1023 Relay Therapeutics I | EUR | 5359 € | 0.2% | 12.65% |
US05465V1089 Ayala Pharmaceutical | EUR | 5155 € | 0.19% | Nueva |
US28106W1036 Edit-Me | EUR | 4615 € | 0.17% | 26.57% |
US14147L1089 Cardiff Oncology Inc | EUR | 4123 € | 0.15% | 37.68% |
US46124U1079 Inventiva SACA | EUR | 2496 € | 0.09% | 22.96% |
US7027121000 Passage Bio Inc | EUR | 2512 € | 0.09% | 42.74% |
US55910K1088 Magenta Therapeutics | EUR | 2321 € | 0.09% | 67.75% |
IL0010852080 Compugen Ltd | EUR | 2276 € | 0.08% | 62.12% |
US45175G1085 Ikena Oncology Inc | EUR | 1809 € | 0.07% | 41.19% |
US1894641000 Clovis Oncology Inc | EUR | 923 € | 0.03% | 95.58% |
US5150691021 Landos Biopharma Inc | EUR | 0 € | 0% | Vendida |
US90041T1088 Turning Point Therap | EUR | 0 € | 0% | Vendida |
US0144421072 Alector Inc | EUR | 0 € | 0% | Vendida |
US5560991094 MacroGenics Inc | EUR | 0 € | 0% | Vendida |
IL0011327454 Vascular Biogenics L | EUR | 0 € | 0% | Vendida |
US6402681083 Nektar Therapeutics | EUR | 0 € | 0% | Vendida |
Cartera ICC
Activo | Div. | Valor | Peso | Dif. |
---|---|---|---|---|
IE00BQ70R696 ETFEner | EUR | 171.680 € | 6.31% | 9.44% |
2022-Q4
Renta Variable Internacional
EUR
357.763,53
11
0
100000
2.490.953 €
6,96 €
Política de Inversión
Operativa con derivadosSe podrá operar con instrumentos financieros derivados negociados en mercados organizados y no organizados de derivados con la finalidad de cobertura y de inversión.
Sectores
- Salud
100.00%
Regiones
- Estados Unidos
89.29%
- Europa
10.61%
- Asía
0.10%
Tipo de Inversión
- Small Cap - Value
23.67%
- Small Cap - Growth
20.05%
- Small Cap - Blend
16.39%
- Medium Cap - Growth
11.62%
- Large Cap - Blend
7.62%
- Large Cap - Growth
7.26%
- Medium Cap - Blend
4.43%
- Large Cap - Value
2.04%
- Medium Cap - Value
0.84%
- No Clasificado
6.07%
Comisiones
Comisión de gestión
Total0.50
0.25
Comisión de depositario
Total0.08
0.04